Ramzi Abboud, MD

Bone Marrow Transplant Specialist, Medical Oncologist

Ramzi Abboud

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Video thumbnail for Ramzi Abboud, MD

Watch video on YouTube

Ramzi Abboud, MD

5 mins

Ramzi Abboud, MD, Medical Oncologist at The Siteman Cancer Center, specializes in treating cancers of the bone marrow, which can include a wide variety of diseases. He also cares for patients undergoing stem cell transplants. Dr. Abboud's basic science research is primarily focused on improving the stem cell transplant process - working to make it safer, more effective, and to reduce the risk of disease relapse following transplant.

Clinical Expertise

  • Bone Marrow Transplant

  • Leukemia

Primary Academic Title

Associate Professor of Medicine, Division of Oncology, Section of Bone Marrow Transplant & Leukemia, WashU Medicine

Board Certification

  • 2017: American Board of Internal Medicine
  • 2020: American Board of Internal Medicine (Medical Oncology)

Training

  • 2017 - 2020: Fellow, Hematology/Oncology, WashU Medicine, St. Louis, MO

Education

  • 2014: MD, University of Rochester, New York, NY

Research & Selected Publications

Research Interest

Immune-based cellular therapies and novel associated toxicities, such as the cytokine release syndrome (CRS); modeling and inhibition of the JAK/STAT pathway in order to make cellular therapies safer and more effective

Research Publications

Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide
Authors:

Modi D, Aljawai YM, DeFor TE, one or more additional authors omitted Abboud R

Journal & Year:

Blood Adv | 2026

Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
Authors:

Abboud R, Schroeder MA, Rettig MP, one or more additional authors omitted DiPersio JF

Journal & Year:

Blood | 2025

Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor specific antibodie…
Authors:

Cochran HC, Slade MJ, Liu C, one or more additional authors omitted Abboud R

Journal & Year:

Leuk Lymphoma | 2024

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors
Authors:

Shaffer BC, Gooptu M, DeFor TE, one or more additional authors omitted Abboud R, one or more additional authors omitted Al Malki MM

Journal & Year:

J Clin Oncol | 2024

Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Authors:

Shah B, Mattison RJ, Abboud R, one or more additional authors omitted Stehman K

Journal & Year:

J Natl Compr Canc Netw | 2024

Pretransplant Desensitization of Donor-Specific Anti-HLA Antibodies with Plasmapheresis and Immunoglobulin Produces Equivalent Outcomes to Patients with No Donor Specific Antibodie…
Authors:

Cochran H, Slade M, Gao F, one or more additional authors omitted Abboud R

Journal & Year:

Res Sq | 2024

Janus kinase inhibition in the treatment and prevention of graft-versus-host disease
Authors:

De Togni E, Cole O, Abboud R

Journal & Year:

Front Immunol | 2024